Incomplete freund's adjuvant

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

225 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

No data

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Melanoma	D008545	—	—	—	1	1	—	—	2

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Ovarian neoplasms	D010051	EFO_0003893	C56	1	2	—	—	—	2
Ovarian epithelial carcinoma	D000077216	—	—	—	1	—	—	—	1
Hypersensitivity	D006967	EFO_0003785	T78.40	—	1	—	—	—	1
Myeloid leukemia acute	D015470	—	C92.0	1	1	—	—	—	1
Colorectal neoplasms	D015179	—	—	1	1	—	—	—	1
Triple negative breast neoplasms	D064726	—	—	1	1	—	—	—	1
Small cell lung carcinoma	D055752	—	—	1	1	—	—	—	1
Myeloid leukemia	D007951	—	C92	1	1	—	—	—	1
Squamous cell carcinoma of head and neck	D000077195	—	—	—	1	—	—	—	1

Indications Phases 1

No data

Indications Without Phase

No data

Epidemiology

Epidemiological information for investigational and approved indications

Drug

General

Drug common name	Incomplete freund's adjuvant
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—